On July 6, 2016, DHG Pharmaceutical Joint-Stock company (DHG Pharma) was honored to welcome strategic partner Taisho Pharmaceutical Co. Ltd (Taisho) for a courtesy visit at the Company headquarter in Can Tho City.


The representatives of Taisho were Mr. Shigeru Uehara – Chief Executive Officer of Taisho Pharmaceutical Co., Ltd.; Mr. Jun Kuroda – Executive Officer; Mr. Tomoyuki Kawata – General Manager, International Technical Operations, Production Headquarters; Mr. Mitsuhiro Kawamura - Deputy General Manager, Corporate Planning Department; Mr. Maki Kamijo - International Administration, International Business Headquarters.


Taisho Pharmaceutical is a company with the largest market share of OTC drugs in Japan, with a history of over 100 years of development, with experiences in management and R&D, possesses advanced production technology ... To partner with Taisho not only follows DHG Pharma’s mission and vision, but also demonstrates the passion of DHG Pharma to grow at the regional level, to enhance the product and brand value and the Company value.


At the meeting, DHG Pharma Chairman Mr. Hoang Nguyen Hoc and Madam Pham Thi Viet Nga – Chief Executive Officer of the Company on behalf of the Board of Directors expressed greetings and sincere gratitude to the representatives from Taisho. DHG Pharma believes this visit will open up many cooperation, partnership and joint ventures opportunities in the production, R&D and trading, to improve the competitiveness of DHG Pharma and Taisho in the regional and global market.


Below are some photos of the meeting: